Why is Strides Pharma falling/rising?

As of 10-Nov, Strides Pharma Science Ltd is experiencing a decline in its stock price, currently at 929.00, which reflects a decrease of 17.95 or 1.9%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 5.61% over the past week. Today's trading saw the stock reach an intraday low of Rs 922, with a weighted average price indicating more volume traded closer to this low. Despite the company declaring positive results for the last nine consecutive quarters, including significant growth in operating profit and attractive valuations compared to peers, the stock's performance has been negatively impacted by a 14.7% decline in profits over the past year.
In the broader market context, Strides Pharma's recent performance contrasts with the Sensex, which has only decreased by 0.53% over the same one-week period. While the stock has shown strong returns over the longer term, including a 41.27% increase year-to-date, the recent drop highlights a short-term weakness that is not reflected in the overall market trend. The falling investor participation, with a significant drop in delivery volume, suggests a lack of confidence among investors, contributing to the stock's current downward trajectory.